Cell and Gene Therapy Market Size, Growth, Share by 2031
The cell and gene therapy market size is projected to reach US$ 28,050.39 million by 2031 from US$ 4,485.00 million in 2023. The market is expected to register a CAGR of 25.8% during 2023–2031. Integration of artificial intelligence (AI) and automation technologies is likely to bring new trends in the market during the forecast period.
Cell and Gene Therapy Market Analysis
The increase in the number of approvals of cell and gene therapies and the rapid popularity of outsourcing cell and gene therapy manufacturing are the factors favoring the cell and gene therapy market progress. Strategic initiatives by companies are also expected to benefit the market in the coming years.
Cell and Gene Therapy Market Overview
The advancements in biotechnology have led to the adoption of personalized treatments for a wide range of indications. Stem cell therapies are being used to treat cancer, neurological disorders, genetic disorders, and other chronic diseases. Further, the advantages of cell therapy include targeted treatment, rapid and efficient recovery, and reduced side effects. Cell therapies are widely adopted worldwide owing to the availability of Food and Drug Administration (FDA) approved products. A few of the cell and gene therapy products approved by the FDA in recent years are mentioned below:
- In April 2024, the FDA approved BEQVEZ for use by Pfizer Inc. to treat adults suffering from moderate to severe hemophilia B who are on factor IX (FIX) prophylaxis therapy. A FIX deficiency causes people with hemophilia B, a rare genetic bleeding illness, to bleed more frequently and for longer periods than healthy people. The disease hinders normal blood clotting.
- In 2023, the FDA approved VYJUVEK, manufactured by Krystal Biotech, Inc., for the treatment of wounds in patients ages 6 months and above with dystrophic epidermolysis bullosa, showing mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene.
Therefore, the increasing number of approvals of cell and gene therapies enhances manufacturing capabilities, which fuels the cell and gene therapy market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell and Gene Therapy Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell and Gene Therapy Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Cell and Gene Therapy Market Drivers and Opportunities
Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing Favors Market
Cell and gene therapy manufacturing is a complex process, which makes the proper execution and monitoring of the operation crucial. Cell and gene therapy manufacturers have a limited number of qualified personnel who know biological and process engineering. Moreover, for experienced teams, managing the attempts to reach the first clinical trial using a manual and open manufacturing method, as well as building a more commercially suitable process, can be challenging. Therefore, these manufacturers choose to work with contract development and manufacturing organizations (CDMOs) to accelerate their clinical studies and commercialization process. CDMOs support product development, manufacturing, clinical trials, and commercialization services to cell and gene therapy companies on a contract basis. Under the partnership with a CDMO, cell and gene therapy manufacturers support scalability, speed to market, access to technical expertise without overhead costs, and cost efficiencies.
Strategic Initiatives by Companies to Create Market Opportunities
Many companies involved in manufacturing cell and gene therapy products focus on collaborations, expansions, agreements, partnerships, new product launches, and other strategic developments. These strategic initiatives help them improve sales, expand geographic reach, and enhance capacities to cater to a large customer base. A few of the significant developments in the cell and gene therapy market are mentioned below.
- In September 2023, Agilent Technologies Inc. signed a Memorandum of Understanding (MOU) with the Advanced Cell Therapy and Research Institute, Singapore (ACTRIS). This agreement aims to improve cell and gene therapy advancements over the next three years.
- In March 2022, Cellevolve Bio partnered with Seattle Children’s Therapeutics to develop and commercialize new multiplex CARs for pediatric cancers. With this collaboration, the companies will focus on the BrainChild research program—a suite of five multiplex CARs—to treat pediatric central nervous system (CNS) malignancies. They aim to leverage the Seattle Children’s Cure Factory facility to conduct early clinical GMP research on new CARs.
The initiation of new businesses to remain competitive in the market through collaborations and partnerships can help accelerate the development of new platforms for cell and gene therapy manufacturing services. Thus, these strategic initiatives by key players are anticipated to create substantial growth opportunities in the cell and gene therapy market during the forecast period.
Cell and Gene Therapy Market Report Segmentation Analysis
Key segments that contributed to the derivation of the cell and gene therapy market analysis are product type, application, and end user.
- Based on type, the cell and gene therapy market is segmented into bifurcated into cell therapy and gene therapy. The cell therapy segment held a larger market share in 2023.
- By services, the market is segmented into process development, cGMP manufacturing, regulatory services, and bioassay services. The process development segment held the largest share of the market in 2023.
- By scale, the market is bifurcated into pre commercial/R and D manufacturing and commercial scale manufacturing. The pre commercial/R and D manufacturing segment held a larger share of the market in 2023.
- By service provider, the market is divided into CDMOs and CMOs. The CDMOs segment dominated the market in 2023.
- Based on end user, the market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, and academic and research institutes. The pharmaceutical and biopharmaceutical companies segment dominated the market in 2023.
Cell and Gene Therapy Market Share Analysis by Geography
The geographic scope of the cell and gene therapy market report is mainly divided into five regions: North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. North America dominated the market in 2023. The North America cell and gene therapy market has been analyzed on the basis of the US, Canada, and Mexico. The cell and gene therapies market growth in the US is attributed to the growing adoption of cell therapies such as stem cell, gene, and immune therapies. Growing incidences of genetic and cellular disorders are leading to increasing demand for cell therapies. According to the American Society of Gene & Cell Therapy (ASGCT), there are currently 3,633 therapies in the pipeline—55% are gene, 22% are non-genetically modified cells, and 23% are RNA—from preclinical through pre-registration. These are focused on various diseases and conditions, varying from cancer to genetic disorders to neurological conditions. As of February 2024, 19 cell and gene therapy products have been approved in the US for treating cancer, eye diseases, and rare hereditary diseases. Also, the country is experiencing an increasing number of start-ups innovating cell therapies. In addition, growing support from the government is promoting the growth of cell therapies, influencing the development of the market. For instance, the American Society of Gene & Cell Therapy (ASGCT), a public organization, offers memberships to scientists, physicians, professionals, and patient advocates who are engaged in gene and cell therapies. ASGCT aims to enhance knowledge, education, and awareness regarding the clinical application of cell and gene therapies.
Cell and Gene Therapy Market Report Scope
Cell and Gene Therapy Market News and Recent Developments
The cell and gene therapy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the cell and gene therapy market are listed below:
- South Korean CDMO Lotte Biologics and Merck KGaA have signed a partnership deal focused on expanding biopharmaceutical production and process development. (Source: Lotte Biologics, Company Website, June 2024)
- Catalent launched a new case management service specifically designed to address the unique challenges associated with the safe and timely delivery of advanced therapies to patients by providing professional supply chain oversight from program start to finish. The supply chain logistics for advanced therapy medicinal products (ATMPs), such as cell and gene therapies, is complex because of their inherent sensitivity, high value, and certain patient-specific complexities of delivering each dose. (Source: Catalent, Company Website, January 2023)
Cell and Gene Therapy Market Report Coverage and Deliverables
The "Cell and Gene Therapy Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Cell and gene therapy market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Cell and gene therapy market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Cell and gene therapy market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the cell and gene therapy market.
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the market in 2023.
Key factors that are driving the market are the increase in number of approvals of cell and gene therapies and rapid popularity of outsourcing cell and gene therapy manufacturing.
Integration of artificial intelligence and automation technologies is likely to remain a key trend in the market.
Thermo Fisher Scientific, Inc.; Merck KGaA; Charles River Laboratories; Cell and Gene Therapy Catapult; Lonza; WuXi AppTec; Takara Bio Inc.; Bristol Myers Squibb; FUJIFILM Holdings Corporation; F. Hoffmann-La Roche Ltd.; and Catalent Biologics are among the key players operating in the market.
The cell and gene therapy market value is estimated to reach US$ 28,050.39 million by 2031.
The cell and gene therapy market is anticipated to record a CAGR of 25.8% during 2023–2031.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Cell and Gene Therapy Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Cell and Gene Therapy Market – Key Market Dynamics
5.1 Cell and Gene Therapy Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increase in Number of Approval of Cell and Gene Therapies
5.2.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.3 Market Restraints
5.3.1 High Cost of Cell and Gene Therapy Manufacturing
5.4 Market Opportunities
5.4.1 Strategic Initiatives by Companies
5.5 Future Trends
5.5.1 Automation of Cell and Gene Therapy Manufacturing Services
5.6 Impact of Drivers and Restraints:
6. Cell and Gene Therapy Market – Global Market Analysis
6.1 Cell and Gene Therapy Market Revenue (US$ Million), 2021–2031
6.2 Cell and Gene Therapy Market Forecast Analysis
7. Cell and Gene Therapy Market Analysis – by Type
7.1 Cell Therapy
7.1.1 Overview
7.1.2 Cell Therapy: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
7.2.1 Overview
7.2.2 Gene Therapy: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8. Cell and Gene Therapy Market Analysis – by Services
8.1 Process Development
8.1.1 Overview
8.1.2 Process Development: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8.2 cGMP Manufacturing
8.2.1 Overview
8.2.2 cGMP Manufacturing: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Regulatory Services
8.3.1 Overview
8.3.2 Regulatory Services: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Bioassay Services
8.4.1 Overview
8.4.2 Bioassay Services: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
9. Cell and Gene Therapy Market Analysis – by Scale
9.1 Pre Commercial/R and D Manufacturing
9.1.1 Overview
9.1.2 Pre Commercial/R and D Manufacturing: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Commercial Scale Manufacturing
9.2.1 Overview
9.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
10. Cell and Gene Therapy Market Analysis – by Service Providers
10.1 CDMOs
10.1.1 Overview
10.1.2 CDMOs: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
10.2 CMOs
10.2.1 Overview
10.2.2 CMOs: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
11. Cell and Gene Therapy Market Analysis – by End User
11.1 Contract Research Organizations
11.1.1 Overview
11.1.2 Contract Research Organizations: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
11.2 Pharmaceutical and Biopharmaceutical Companies
11.2.1 Overview
11.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
11.3 Academic and Research Institutes
11.3.1 Overview
11.3.2 Academic and Research Institutes: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12. Cell and Gene Therapy Market – Geographical Analysis
12.1 Overview
12.2 North America
12.2.1 North America Cell and Gene Therapy Market Overview
12.2.2 North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.2.3 North America: Cell and Gene Therapy Market Breakdown, by Type
12.2.3.1 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Type
12.2.3.1.1 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Cell Therapy
12.2.3.1.2 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Gene Therapy
12.2.4 North America: Cell and Gene Therapy Market Breakdown, by Services
12.2.4.1 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Services
12.2.5 North America: Cell and Gene Therapy Market Breakdown, by Scale
12.2.5.1 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Scale
12.2.6 North America: Cell and Gene Therapy Market Breakdown, by Service Providers
12.2.6.1 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Service Providers
12.2.7 North America: Cell and Gene Therapy Market Breakdown, by End User
12.2.7.1 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by End User
12.2.8 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.2.8.1 North America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.2.8.2 United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.2.8.2.1 United States: Cell and Gene Therapy Market Breakdown, by Type
12.2.8.2.1.1 United States: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.2.8.2.1.2 United States: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.2.8.2.2 United States: Cell and Gene Therapy Market Breakdown, by Services
12.2.8.2.3 United States: Cell and Gene Therapy Market Breakdown, by Scale
12.2.8.2.4 United States: Cell and Gene Therapy Market Breakdown, by Service Providers
12.2.8.2.5 United States: Cell and Gene Therapy Market Breakdown, by End User
12.2.8.3 Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.2.8.3.1 Canada: Cell and Gene Therapy Market Breakdown, by Type
12.2.8.3.1.1 Canada: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.2.8.3.1.2 Canada: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.2.8.3.2 Canada: Cell and Gene Therapy Market Breakdown, by Services
12.2.8.3.3 Canada: Cell and Gene Therapy Market Breakdown, by Scale
12.2.8.3.4 Canada: Cell and Gene Therapy Market Breakdown, by Service Providers
12.2.8.3.5 Canada: Cell and Gene Therapy Market Breakdown, by End User
12.2.8.4 Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.2.8.4.1 Mexico: Cell and Gene Therapy Market Breakdown, by Type
12.2.8.4.1.1 Mexico: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.2.8.4.1.2 Mexico: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.2.8.4.2 Mexico: Cell and Gene Therapy Market Breakdown, by Services
12.2.8.4.3 Mexico: Cell and Gene Therapy Market Breakdown, by Scale
12.2.8.4.4 Mexico: Cell and Gene Therapy Market Breakdown, by Service Providers
12.2.8.4.5 Mexico: Cell and Gene Therapy Market Breakdown, by End User
12.3 Europe
12.3.1 Europe Cell and Gene Therapy Market Overview
12.3.2 Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.3.3 Europe: Cell and Gene Therapy Market Breakdown, by Type
12.3.3.1 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Type
12.3.3.1.1 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Cell Therapy
12.3.3.1.2 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Gene Therapy
12.3.4 Europe: Cell and Gene Therapy Market Breakdown, by Services
12.3.4.1 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Services
12.3.5 Europe: Cell and Gene Therapy Market Breakdown, by Scale
12.3.5.1 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Scale
12.3.6 Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.6.1 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Service Providers
12.3.7 Europe: Cell and Gene Therapy Market Breakdown, by End User
12.3.7.1 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by End User
12.3.8 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.3.8.1 Europe: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.3.8.2 United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.3.8.2.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.2.1.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.2.1.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.2.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.2.3 United Kingdom: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.2.4 United Kingdom: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.2.5 United Kingdom: Cell and Gene Therapy Market Breakdown, by End User
12.3.8.3 Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.3.8.3.1 Germany: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.3.1.1 Germany: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.3.1.2 Germany: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.3.2 Germany: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.3.3 Germany: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.3.4 Germany: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.3.5 Germany: Cell and Gene Therapy Market Breakdown, by End User
12.3.8.4 France: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.3.8.4.1 France: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.4.1.1 France: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.4.1.2 France: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.4.2 France: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.4.3 France: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.4.4 France: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.4.5 France: Cell and Gene Therapy Market Breakdown, by End User
12.3.8.5 Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.3.8.5.1 Italy: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.5.1.1 Italy: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.5.1.2 Italy: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.5.2 Italy: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.5.3 Italy: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.5.4 Italy: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.5.5 Italy: Cell and Gene Therapy Market Breakdown, by End User
12.3.8.6 Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.3.8.6.1 Spain: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.6.1.1 Spain: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.6.1.2 Spain: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.6.2 Spain: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.6.3 Spain: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.6.4 Spain: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.6.5 Spain: Cell and Gene Therapy Market Breakdown, by End User
12.3.8.7 Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.3.8.7.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Type
12.3.8.7.1.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.3.8.7.1.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.3.8.7.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Services
12.3.8.7.3 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Scale
12.3.8.7.4 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
12.3.8.7.5 Rest of Europe: Cell and Gene Therapy Market Breakdown, by End User
12.4 Asia Pacific
12.4.1 Asia Pacific Cell and Gene Therapy Market Overview
12.4.2 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.4.3 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Type
12.4.3.1 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Type
12.4.3.1.1 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Cell Therapy
12.4.3.1.2 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Gene Therapy
12.4.4 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Services
12.4.4.1 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Services
12.4.5 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Scale
12.4.5.1 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Scale
12.4.6 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.6.1 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Service Providers
12.4.7 Asia Pacific: Cell and Gene Therapy Market Breakdown, by End User
12.4.7.1 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by End User
12.4.8 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.4.8.1 Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.4.8.2 China: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.4.8.2.1 China: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.2.1.1 China: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.2.1.2 China: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.2.2 China: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.2.3 hina: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.2.4 China: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.2.5 China: Cell and Gene Therapy Market Breakdown, by End User
12.4.8.3 Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.4.8.3.1 Japan: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.3.1.1 Japan: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.3.1.2 Japan: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.3.2 Japan: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.3.3 Japan: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.3.4 Japan: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.3.5 Japan: Cell and Gene Therapy Market Breakdown, by End User
12.4.8.4 India: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.4.8.4.1 India: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.4.1.1 India: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.4.1.2 India: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.4.2 India: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.4.3 India: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.4.4 India: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.4.5 India: Cell and Gene Therapy Market Breakdown, by End User
12.4.8.5 Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.4.8.5.1 Australia: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.5.1.1 Australia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.5.1.2 Australia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.5.2 Australia: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.5.3 Australia: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.5.4 Australia: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.5.5 Australia: Cell and Gene Therapy Market Breakdown, by End User
12.4.8.6 South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.4.8.6.1 South Korea: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.6.1.1 South Korea: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.6.1.2 South Korea: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.6.2 South Korea: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.6.3 South Korea: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.6.4 South Korea: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.6.5 South Korea: Cell and Gene Therapy Market Breakdown, by End User
12.4.8.7 Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.4.8.7.1 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Type
12.4.8.7.1.1 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.4.8.7.1.2 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.4.8.7.2 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Services
12.4.8.7.3 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Scale
12.4.8.7.4 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Service Providers
12.4.8.7.5 Rest of APAC: Cell and Gene Therapy Market Breakdown, by End User
12.5 Middle East and Africa
12.5.1 Middle East and Africa Cell and Gene Therapy Market Overview
12.5.2 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.5.3 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type
12.5.3.1 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Type
12.5.3.1.1 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Cell Therapy
12.5.3.1.2 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Gene Therapy
12.5.4 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services
12.5.4.1 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Services
12.5.5 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale
12.5.5.1 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Scale
12.5.6 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
12.5.6.1 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Service Providers
12.5.7 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User
12.5.7.1 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by End User
12.5.8 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.5.8.1 Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.5.8.2 South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.5.8.2.1 South Africa: Cell and Gene Therapy Market Breakdown, by Type
12.5.8.2.1.1 South Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.5.8.2.1.2 South Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.5.8.2.2 South Africa: Cell and Gene Therapy Market Breakdown, by Services
12.5.8.2.3 South Africa: Cell and Gene Therapy Market Breakdown, by Scale
12.5.8.2.4 South Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
12.5.8.2.5 South Africa: Cell and Gene Therapy Market Breakdown, by End User
12.5.8.3 Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.5.8.3.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Type
12.5.8.3.1.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.5.8.3.1.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.5.8.3.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Services
12.5.8.3.3 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Scale
12.5.8.3.4 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Service Providers
12.5.8.3.5 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by End User
12.5.8.4 United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.5.8.4.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Type
12.5.8.4.1.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.5.8.4.1.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.5.8.4.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Services
12.5.8.4.3 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Scale
12.5.8.4.4 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Service Providers
12.5.8.4.5 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by End User
12.5.8.5 Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.5.8.5.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type
12.5.8.5.1.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.5.8.5.1.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.5.8.5.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services
12.5.8.5.3 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale
12.5.8.5.4 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
12.5.8.5.5 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User
12.6 South and Central America
12.6.1 South and Central America Cell and Gene Therapy Market Overview
12.6.2 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.6.3 South and Central America: Cell and Gene Therapy Market Breakdown, by Type
12.6.3.1 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Type
12.6.3.1.1 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Cell Therapy
12.6.3.1.2 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Gene Therapy
12.6.4 South and Central America: Cell and Gene Therapy Market Breakdown, by Services
12.6.4.1 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Services
12.6.5 South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
12.6.5.1 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Scale
12.6.6 South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
12.6.6.1 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Service Providers
12.6.7 South and Central America: Cell and Gene Therapy Market Breakdown, by End User
12.6.7.1 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by End User
12.6.8 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.6.8.1 South and Central America: Cell and Gene Therapy Market – Revenue and Forecast Analysis – by Country
12.6.8.2 Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.6.8.2.1 Brazil: Cell and Gene Therapy Market Breakdown, by Type
12.6.8.2.1.1 Brazil: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.6.8.2.1.2 Brazil: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.6.8.2.2 Brazil: Cell and Gene Therapy Market Breakdown, by Services
12.6.8.2.3 Brazil: Cell and Gene Therapy Market Breakdown, by Scale
12.6.8.2.4 Brazil: Cell and Gene Therapy Market Breakdown, by Service Providers
12.6.8.2.5 Brazil: Cell and Gene Therapy Market Breakdown, by End User
12.6.8.3 Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.6.8.3.1 Argentina: Cell and Gene Therapy Market Breakdown, by Type
12.6.8.3.1.1 Argentina: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.6.8.3.1.2 Argentina: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.6.8.3.2 Argentina: Cell and Gene Therapy Market Breakdown, by Services
12.6.8.3.3 Argentina: Cell and Gene Therapy Market Breakdown, by Scale
12.6.8.3.4 Argentina: Cell and Gene Therapy Market Breakdown, by Service Providers
12.6.8.3.5 Argentina: Cell and Gene Therapy Market Breakdown, by End User
12.6.8.4 Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
12.6.8.4.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Type
12.6.8.4.1.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Cell Therapy
12.6.8.4.1.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Gene Therapy
12.6.8.4.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Services
12.6.8.4.3 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
12.6.8.4.4 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
12.6.8.4.5 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in Cell and Gene Therapy Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Thermo Fisher Scientific Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Merck KGaA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Charles River Laboratories InternationalInc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Cell and Gene Therapy Catapult
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Lonza Group AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 WuXi AppTec Co Ltd
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Takara Bio Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 FUJIFILM Holdings Corp
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 F. Hoffmann-La Roche Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Catalent Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Lotte Corp
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
List of Tables
Table 1. Cell and Gene Therapy Market Segmentation
Table 2. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 4. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million) – by Cell Therapy
Table 5. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million) – by Gene Therapy
Table 6. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million) – by Services
Table 7. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million) – by Scale
Table 8. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million) – by Service Providers
Table 9. Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 10. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 11. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 12. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 13. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 14. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 15. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 16. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 17. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 18. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 19. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 20. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 21. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 22. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 23. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 24. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 25. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 26. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 27. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 28. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 29. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 30. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 31. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 32. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 33. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 34. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 35. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 36. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 37. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 38. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 39. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 40. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 41. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 42. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 43. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 44. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 45. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 46. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 47. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 48. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 49. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 50. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 51. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 52. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 53. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 54. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 55. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 56. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 57. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 58. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 59. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 60. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 61. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 62. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 63. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 64. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 65. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 66. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 67. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 68. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 69. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 70. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 71. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 72. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 73. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 74. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 75. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 76. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 77. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 78. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 79. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 80. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 81. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 82. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 83. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 84. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 85. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 86. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 87. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 88. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 89. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 90. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 91. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 92. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 93. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 94. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 95. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 96. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 97. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 98. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 99. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 100. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 101. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 102. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 103. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 104. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 105. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 106. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 107. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 108. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 109. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 110. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 111. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 112. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 113. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 114. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 115. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 116. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 117. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 118. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 119. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 120. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 121. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 122. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 123. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 124. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 125. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 126. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 127. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 128. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 129. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 130. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 131. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 132. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 133. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 134. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 135. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 136. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 137. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 138. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 139. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 140. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 141. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 142. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 143. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 144. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 145. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 146. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 147. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 148. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 149. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 150. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 151. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 152. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 153. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 154. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 155. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 156. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 157. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 158. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 159. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 160. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 161. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 162. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 163. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 164. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 165. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 166. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 167. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 168. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 169. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 170. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 171. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 172. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 173. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 174. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 175. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 176. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 177. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 178. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 179. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 180. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 181. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 182. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Country
Table 183. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 184. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 185. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 186. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 187. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 188. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 189. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 190. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 191. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 192. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 193. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 194. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 195. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 196. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 197. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Type
Table 198. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Cell Therapy
Table 199. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Gene Therapy
Table 200. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Services
Table 201. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Scale
Table 202. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by Service Providers
Table 203. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million) – by End User
Table 204. Recent Organic Growth Strategies in Cell and Gene Therapy Market
Table 205. Recent Inorganic Growth Strategies in the Tympanostomy products Market
List of Figures
Figure 1. Cell and Gene Therapy Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Cell and Gene Therapy Market Revenue (US$ Million), 2021–2031
Figure 5. Cell and Gene Therapy Market Share (%) – by Type (2023 and 2031)
Figure 6. Cell Therapy: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Gene Therapy: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Cell and Gene Therapy Market Share (%) – by Services (2023 and 2031)
Figure 9. Process Development: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. cGMP Manufacturing: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Regulatory Services: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Bioassay Services: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Cell and Gene Therapy Market Share (%) – by Scale (2023 and 2031)
Figure 14. Pre Commercial/R and D Manufacturing: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Commercial Scale Manufacturing: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Cell and Gene Therapy Market Share (%) – by Service Providers (2023 and 2031)
Figure 17. CDMOs: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. CMOs: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Cell and Gene Therapy Market Share (%) – by End User (2023 and 2031)
Figure 20. Contract Research Organizations: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Academic and Research Institutes: Cell and Gene Therapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Cell and Gene Therapy Market Breakdown by Region, 2023 and 2031 (%)
Figure 24. North America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 25. North America: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
Figure 26. North America: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
Figure 27. North America: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
Figure 28. North America: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
Figure 29. North America: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 30. United States: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 31. Canada: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. Mexico: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. Europe: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
Figure 35. Europe: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
Figure 36. Europe: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
Figure 37. Europe: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
Figure 38. Europe: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
Figure 39. Europe: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 40. United Kingdom: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. Germany: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. France: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Italy: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. Spain: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Rest of Europe: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. Asia Pacific: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
Figure 48. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
Figure 49. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
Figure 50. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
Figure 51. Asia Pacific: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
Figure 52. Asia Pacific: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 53. China: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. Japan: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 55. India: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 56. Australia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 57. South Korea: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 58. Rest of APAC: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 59. Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 60. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
Figure 61. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
Figure 62. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
Figure 63. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
Figure 64. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
Figure 65. Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 66. South Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 67. Saudi Arabia: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 68. United Arab Emirates: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 69. Rest of Middle East and Africa: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 70. South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 71. South and Central America: Cell and Gene Therapy Market Breakdown, by Type (2023 and 2031)
Figure 72. South and Central America: Cell and Gene Therapy Market Breakdown, by Services (2023 and 2031)
Figure 73. South and Central America: Cell and Gene Therapy Market Breakdown, by Scale (2023 and 2031)
Figure 74. South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers (2023 and 2031)
Figure 75. South and Central America: Cell and Gene Therapy Market Breakdown, by End User (2023 and 2031)
Figure 76. South and Central America: Cell and Gene Therapy Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 77. Brazil: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 78. Argentina: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 79. Rest of South and Central America: Cell and Gene Therapy Market – Revenue and Forecast to 2031(US$ Million)
Figure 80. Growth Strategies in Cell and Gene Therapy Market
The List of Companies - Cell and Gene Therapy Market
- Thermo Fisher Scientific, Inc.;
- Merck KGaA;
- Charles River Laboratories;
- Cell and Gene Therapy Catapult;
- Lonza; WuXi AppTec;
- Takara Bio Inc.;
- Bristol Myers Squibb;
- FUJIFILM Holdings Corporation;
- F. Hoffmann-La Roche Ltd.;
- Catalent Biologics
- Cell Therapies Pty Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For